600521.SS

Zhejiang Huahai Pharmaceutical Co., Ltd. [600521.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600521.SS Stock Summary

Top 10 Correlated Stocks

600521.SS


In the News

600521.SS Financial details

Company Rating
Strong Buy
Market Cap
19.12B
Income
1.09B
Revenue
8.64B
Book val./share
5.61
Cash/share
0.82
Dividend
0.24
Dividend %
1.76%
Employees
7.68K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
17.93
Forward P/E
13.18
PEG
1.45
P/S
2.28
P/B
2.43
P/C
15.76
P/FCF
-55.37
Quick Ratio
0.86
Current Ratio
1.63
Debt / Equity
0.86
LT Debt / Equity
0.56
-
-
EPS (TTM)
0.76
EPS next Y
0.98
EPS next Q
0.2
EPS this Y
138.24%
EPS next Y
28.29%
EPS next 5Y
28.29%
EPS last 5Y
58.18%
Revenue last 5Y
10.16%
Revenue Q/Q
-14.4%
EPS Q/Q
-59.26%
-
-
-
-
SMA20
-7.14%
SMA50
-7.14%
SMA100
-18.75%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
14%
ROC
0.1%
Gross Margin
61%
Oper. Margin
17%
Profit Margin
13%
Payout
51%
Shs Outstand
1.44B
Shs Float
810.81M
-
-
-
-
Target Price
-
52W Range
10.71-21.03
52W High
-38.48%
52W Low
+29.2%
RSI
37
Rel Volume
0.64
Avg Volume
11.14M
Volume
7.09M
Perf Week
-5.9%
Perf Month
-4.58%
Perf Quarter
-
Perf Half Y
-23.82%
-
-
-
-
Beta
0.126
-
-
Volatility
0.34%, 0.33%
Prev Close
1.1%
Price
12.92
Change
-0.77%

600521.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.883.884.464.635.73
Net income per share
0.080.410.640.340.81
Operating cash flow per share
0.051.261.070.650.86
Free cash flow per share
-0.80.690.19-1.04-0.74
Cash per share
0.691.071.521.311.05
Book value per share
3.14.044.484.575.23
Tangible book value per share
2.493.433.763.654.09
Share holders equity per share
3.14.044.484.575.23
Interest debt per share
2.812.542.884.054.91
Market cap
12.5B21.8B49.12B31.06B31.52B
Enterprise value
15.14B23.6B50.96B34.82B37.01B
P/E ratio
116.2338.2752.8363.7126.99
Price to sales ratio
2.454.057.574.683.81
POCF ratio
184.0612.4331.5833.125.36
PFCF ratio
-11.8322.71176.08-20.76-29.35
P/B Ratio
3.073.897.544.744.18
PTB ratio
3.073.897.544.744.18
EV to sales
2.974.387.865.244.48
Enterprise value over EBITDA
19.5615.826.9922.2814.7
EV to operating cash flow
222.9713.4632.7637.129.78
EV to free cash flow
-14.3324.59182.67-23.27-34.48
Earnings yield
0.010.030.020.020.04
Free cash flow yield
-0.080.040.01-0.05-0.03
Debt to equity
0.870.590.620.860.91
Debt to assets
0.340.310.310.360.38
Net debt to EBITDA
3.411.210.972.412.18
Current ratio
1.091.572.261.611.65
Interest coverage
3.43.679.515.227.03
Income quality
0.52.891.561.951.06
Dividend Yield
0.020.010.010.010.01
Payout ratio
2.860.370.420.790.27
Sales general and administrative to revenue
0.080.070.080.10.08
Research and developement to revenue
0.080.090.090.140.11
Intangibles to total assets
0.090.090.10.10.1
Capex to operating cash flow
-16.56-0.45-0.82-2.59-1.86
Capex to revenue
-0.22-0.15-0.2-0.37-0.28
Capex to depreciation
-3.26-1.93-2.71-4.32-3.45
Stock based compensation to revenue
0000.010.01
Graham number
2.396.18.035.929.77
ROIC
0.050.070.10.040.08
Return on tangible assets
0.010.060.080.040.07
Graham Net
-2-0.9-1.02-2.74-3.47
Working capital
446.19M1.91B3.63B2.58B3.11B
Tangible asset value
3.27B4.76B5.47B5.23B5.89B
Net current asset value
-948.25M316.09M256.45M-1.88B-2.5B
Invested capital
0.870.590.620.860.91
Average receivables
1.89B1.75B1.67B1.95B2.49B
Average payables
711M619.81M735.69M888.06M1.04B
Average inventory
1.89B2.2B2.29B2.55B3.06B
Days sales outstanding
146.0399.6104.97111.3130.32
Days payables outstanding
117.9499.05138.78121.13141.1
Days of inventory on hand
388.91380.56367.51376.18395.95
Receivables turnover
2.53.663.483.282.8
Payables turnover
3.093.682.633.012.59
Inventory turnover
0.940.960.990.970.92
ROE
0.030.10.140.070.15
Capex per share
-0.86-0.57-0.88-1.7-1.61

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.461.691.431.551.33
Net income per share
0.160.260.120.270.11
Operating cash flow per share
0.160.260.120.360.39
Free cash flow per share
-0.21-0.24-0.240.070.16
Cash per share
0.941.051.281.390.82
Book value per share
5.165.275.375.735.61
Tangible book value per share
4.14.114.194.514.38
Share holders equity per share
5.165.275.375.735.61
Interest debt per share
4.764.835.235.444.86
Market cap
26.42B31.32B29.07B26.58B24.42B
Enterprise value
31.62B36.82B34.82B32.46B30.27B
P/E ratio
29.1620.9842.0216.7939.97
Price to sales ratio
13.1212.914.1211.8912.76
POCF ratio
116.6683.93168.0851.4543.53
PFCF ratio
-90.32-89.27-85.51268.75103.19
P/B Ratio
3.724.153.763.213.02
PTB ratio
3.724.153.763.213.02
EV to sales
15.715.1716.9114.5215.82
Enterprise value over EBITDA
63.6370.24103.5565.63103.76
EV to operating cash flow
139.698.66201.3262.8253.96
EV to free cash flow
-108.08-104.94-102.42328.16127.91
Earnings yield
0.010.010.010.010.01
Free cash flow yield
-0.01-0.01-0.0100.01
Debt to equity
0.910.910.970.940.86
Debt to assets
0.380.380.40.40.38
Net debt to EBITDA
10.4610.4917.111.8820.06
Current ratio
1.671.651.651.581.63
Interest coverage
8.049.143.757.554.02
Income quality
1111.313.67
Dividend Yield
0.01000.010.01
Payout ratio
0.830.130.340.661.23
Sales general and administrative to revenue
0.28-0.070.1400.32
Research and developement to revenue
0.110.110.10.10.13
Intangibles to total assets
0.10.10.10.10.11
Capex to operating cash flow
-2.29-1.94-2.97-0.81-0.58
Capex to revenue
-0.26-0.3-0.25-0.19-0.17
Capex to depreciation
-2.85-3.97-2.58-2.10.84
Stock based compensation to revenue
-0.010.0200.01-0.02
Graham number
4.375.563.815.953.66
ROIC
0.020.030.010.020.01
Return on tangible assets
0.010.020.010.020.01
Graham Net
-3.41-3.49-3.53-3.53-3.54
Working capital
2.89B3.11B3.22B3.23B2.95B
Tangible asset value
5.65B5.89B6.03B6.51B6.3B
Net current asset value
-2.35B-2.5B-2.58B-2.3B-2.53B
Invested capital
0.910.910.970.940.86
Average receivables
2.43B2.75B2.92B2.95B2.93B
Average payables
989.82M1.09B1.2B1.24B1.32B
Average inventory
3.22B3.33B3.36B3.4B3.49B
Days sales outstanding
113.89109.41125.86121.25134.03
Days payables outstanding
110.21126.33127.37133.58145.33
Days of inventory on hand
369.26354.49355.99359.03379
Receivables turnover
0.790.820.720.740.67
Payables turnover
0.820.710.710.670.62
Inventory turnover
0.240.250.250.250.24
ROE
0.030.050.020.050.02
Capex per share
-0.38-0.51-0.36-0.29-0.23

600521.SS Frequently Asked Questions

What is Zhejiang Huahai Pharmaceutical Co., Ltd. stock symbol ?

Zhejiang Huahai Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 600521.SS

What is Zhejiang Huahai Pharmaceutical Co., Ltd. stock quote today ?

Zhejiang Huahai Pharmaceutical Co., Ltd. stock price is $12.92 today.

Is Zhejiang Huahai Pharmaceutical Co., Ltd. stock public?

Yes, Zhejiang Huahai Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap